Kairos Pharma Ltd. (KAPA)
1.73
-0.08
(-4.42%)
USD |
NYAM |
Sep 18, 16:00
1.75
+0.02
(+1.16%)
After-Hours: 20:00
Kairos Pharma Total Assets (Quarterly) : 4.456M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.456M |
| March 31, 2026 | 5.744M |
| December 31, 2025 | 6.779M |
| September 30, 2025 | 8.066M |
| June 30, 2025 | 6.673M |
| March 31, 2025 | 7.937M |
| December 31, 2024 | 6.216M |
| September 30, 2024 | 5.004M |
| Date | Value |
|---|---|
| June 30, 2024 | 1.03M |
| March 31, 2024 | 0.972M |
| December 31, 2023 | 0.965M |
| September 30, 2023 | 0.948M |
| June 30, 2023 | 0.978M |
| March 31, 2023 | 1.005M |
| December 31, 2022 | 1.036M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.265M |
| Shareholders Equity (Quarterly) | 4.191M |
| Current Ratio | 11.98 |